Skip to content

Section archive

Page 10 of 13

Government

Updates from the FDA, CDC and other agencies.

FDA says its review of an August 2009 study on heart-related risks with Avandia is still under way, with no new conclusions or recommendations yet, and it will hold a public meeting in July 2010. Patients are told not to stop rosiglitazone without talking to their clinician.

1 min read

223 stories